Oppenheimer Asset Management Inc. Bristol Myers Squibb CO Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 499,533 shares of BMY stock, worth $22.8 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
499,533
Previous 504,149
0.92%
Holding current value
$22.8 Million
Previous $30.7 Million
24.8%
% of portfolio
0.28%
Previous 0.4%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,664Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.89 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.24 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.93 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.32 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.23 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...